News
OTRK
0.2360
-9.92%
-0.0260
Weekly Report: what happened at OTRK last week (0422-0426)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers ImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday's pre-market session. Nuwellis shares increased by 24.1% and VolitionRX stock increased by 16.66% during the same time period. Losers Abeona Therapeutics and OncoCyte stock declined by 45.7% and 16.34% respectively.
Benzinga · 04/23 12:06
Weekly Report: what happened at OTRK last week (0415-0419)?
Weekly Report · 04/22 12:33
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 67.1% to $5.42 during Thursday's regular session. Aileron Therapeutics (NASdaq:ALRN) and 23andMe Holding moved upwards. Losers SeaStar Medical Holding and Aptorum Gr stock decreased by 27.0% during the session.
Benzinga · 04/18 16:31
Ontrak, Inc. in Turmoil: Class Action Lawsuit and Shareholder Claims Pose Threat to Financial Stability
TipRanks · 04/18 06:00
Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
U.S. Stocks traded lower on Wednesday, with the Nasdaq Composite falling more than 100 points. The Dow traded up 0.04% to 37,813.77 while the NASDAQ fell 0.78% to 15,742.21. European shares closed higher on Wednesday. In commodity news, oil traded down 3% to $82.78 and gold traded down 0.8%. U.s. Bancorp reported upbeat first-quarter FY24 earnings. Utilities shares rose by 1.5% on Wednesday after the company reported upbeat results.
Benzinga · 04/17 18:34
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
The Travelers Companies, Inc. Shares dipped 8.1% to $205.03 on Wednesday. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. InVO Bioscience shares shot up 256% after the company reported a year-over-year increase in fourth-quarter revenue.
Benzinga · 04/17 17:36
Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge
U.S. Stocks traded lower midway through trading on Wednesday. The Dow Jones index fell around 100 points and the NASDAQ fell 1.16%. Crude oil inventories climbed by 2.735 million barrels in the week ended April 12. Utilities shares rose by 0.7% on Wednesday; information technology shares fell 0.9%. European shares were higher today.
Benzinga · 04/17 16:44
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
INVO Bioscience shares increased by 93.4% to $1.47 during Wednesday's pre-market session. The company's, Q4 earnings came out yesterday. Clene shares moved upwards by 40.8% and Galera Therapeutics shares moved up by 31.6%. Sage Therapeutic (NASDAQ:SAGE) stock decreased by 19.4%.
Benzinga · 04/17 12:08
Ontrak (OTRK) Receives a Buy from Roth MKM
TipRanks · 04/17 11:55
S&P Futures Climb as Investors Shift Focus to Earnings
NASDAQ · 04/17 11:09
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
Wall Street expects Abbott Laboratories to report quarterly earnings at 95 cents per share before the opening bell. Ontrak, Inc. Reported worse-than-expected fourth-quarter financial results. Analysts expect U.S. Bancorp to post quarterly earnings before the markets open.
Benzinga · 04/17 06:06
S&P Futures Tick Higher as Investors Shift Focus to Earnings
June S&P 500 E-Mini futures are trending up +0.30% this morning. Wall Street's major indices ended mixed in yesterday's trading session. Live Nation Entertainment plunged over -7% after reporting weaker-than-expected Q1 results. U.S. Building permits fell to an 8-month low in March. Eurozone inflation slows to 2.4% in March, less than expected.
Barchart · 04/17 04:33
OTRK Stock Earnings: Ontrak Reported Results for Q4 2023
Ontrak reported results for the fourth quarter of 2023. The company reported earnings per share of -27 cents. Ontrak reported revenue of $3.54 million. The stock is down 2.7% in the last week. The company has a market value of $1.2 billion.
Investorplace · 04/17 00:53
Ontrak, Inc. Annual Report for Fiscal Year Ended December 31, 2023
Press release · 04/16 23:37
Ontrak Inc reports results for the quarter ended in December - Earnings Summary
Ontrak Inc reports results for the quarter ended in December. Revenue rose 41% to $3.54 million from a year ago. The company reported a quarterly loss of $8.63 million. Ontrak Inc shares had fallen by 13.1% this quarter and gained 9.7% this year.
Reuters · 04/16 21:49
UPDATE: Ontrak Q4 2023 Adj EPS $(0.27) Misses $(0.21) Estimate, Sales $3.539 Miss $4.037M Estimate
Ontrak (NASDAQ:OTRK) reported quarterly losses of $0.27 per share. The company reported quarterly sales of $3.539 which missed the analyst consensus estimate of $4.037 million by 100.00%. The company also missed the quarterly sales estimate by 28.57 percent.
Benzinga · 04/16 20:29
Ontrak Q4 Adj EPS $(0.27) Up From $(2.19) YoY, Sales $3.54M Up From $2.51M YoY
Ontrak (NASDAQ:OTRK) reported quarterly losses of $0.27 per share. The company reported $3.54 million in sales this quarter. This is a 41.00 percent increase over sales of $2.51 million the same period last year.
Benzinga · 04/16 20:08
*Ontrak Sees 1Q Rev $2.5M-$2.9M >OTRK
Dow Jones · 04/16 20:08
Ontrak Non-GAAP EPS of -$0.27 misses by $0.06, revenue of $3.5M misses by $0.54M
Seeking Alpha · 04/16 20:07
More
Webull provides a variety of real-time OTRK stock news. You can receive the latest news about Ontrak Inc through multiple platforms. This information may help you make smarter investment decisions.
About OTRK
Ontrak, Inc. is an artificial intelligence (AI) and telehealth-enabled healthcare company. The Company identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. It engages individuals with anxiety, depression, substance-use disorders and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. Its technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of its personalized care program. The Company integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaches.